AzTrials
AzTrials

Conduct DisorderPhase 1/2NCT06831123

Pathways 2 Success

A Phase 1/2 study testing L2B, L2B + App and skills for success in people with Conduct Disorder and Oppositional Defiant Disorder, run by University of Minnesota at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

This study involves a 3-arm randomized controlled trial designed to investigate the feasibility and acceptability of three preventive interventions designed to reduce risk for escalations in adolescent conduct problems. Read more about this study

Who is it for?
Ages 13 to 17 years
What is being tested?
L2B, L2B + App and skills for success
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteUnited States
Study dates
12 Mar 2025to 28 Feb 2027
Phase
Phase 1/2
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 17 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • A 9th or 10th grade student in a partner school district
  • Referral due to elevated social/emotional risk indicated on a standardized screening tool or a referral from school support staff due to concerns about school-based conduct problems
  • Adolescents and their parents must be fluent in English

Who cannot join

  • Currently receiving special education services (i.e., an IEP) due to a behavioral or emotional disturbance
  • Existing diagnoses of autism spectrum disorder, pervasive developmental disorders, developmental/intellectual disability, or serious psychiatric disorders requiring specialized mental health treatment (e.g., psychosis, bipolar, substance use disorder, etc.)

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nicole Morrell contact

612-624-2600

morre006@umn.edu

United States1 site, 1 recruiting
  • University of Minnesota

    Minneapolis, Minnesota, 55414

    Timothy Piehler, tpiehler@umn.edu

    Recruiting

Other trials in United States

About this study

Official title: Pathways 2 Success: A Study of School-Based Prevention Programs Supporting Positive Adolescent Development

This study involves a 3-arm randomized controlled trial designed to investigate the feasibility and acceptability of three preventive interventions designed to reduce risk for escalations in adolescent conduct problems. High school students identified to be at risk for conduct problems will be randomly assigned to one of three intervention options, including a mindfulness-based program, a mindfulness-based program augmented by a new mobile app, and a life skills program. Assessments related to intervention outcomes will be completed by adolescents, parents/guardians, and teachers at baseline, 2 weeks post-intervention, and at a 3-month follow-up.

Being tested
L2B, L2B + App, skills for success
Medical subject headings
Conduct Disorder, Oppositional Defiant Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • L2BBehavioural

    a 6-session, group-based intervention that helps youth develop mindfulness skills

  • L2B + AppBehavioural

    the Learning to Breathe plus App condition, the 6-session L2B intervention augmented by a mobile application designed to support the use of mindfulness skills in daily life

  • skills for successBehavioural

    a 6-session life skills intervention designed to support decision making and healthy relationships

Study groups in NCT06831123
Study groupRoleWhat they receive
The Learning to breathe (L2B)Experimentalrandomized to the Learning to Breathe (L2B) mindfulness intervention
Receives: Behavioral: L2B
L2B+AppExperimentalrandomized to the Learning to Breathe plus App condition
Receives: Behavioral: L2B + App
Skills for SuccessExperimentalrandomized to Skills for Success
Receives: Behavioral: skills for success

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Add Health Self-Report of Delinquency

    A rating scale used to evaluate the number of times in the past month adolescents have committed 17 different antisocial acts.

    A rating scale used to evaluate the number of times in the past month adolescents have committed 17 different antisocial acts. Scores range from 0 to 17, with higher scores reflecting greater engagement in delinquent behaviors.

    Measured: Baseline; up to 15 weeks; through study completion, approximately 6 months

  2. Behavioral Rating Inventory of Executive Functioning - Second Edition Screening Form

    A 12-item rating scale that evaluates executive functioning A 12-item rating scale that evaluates executive functioning. Scores are reported as T-scores, with higher scores reflecting greater levels of executive functioning difficulties.

    Measured: Baseline; up to 15 weeks; through study completion, approximately 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2025
  2. Study start12 Mar 2025
  3. Primary completion28 Feb 2027 (estimated)
  4. Study completion28 Feb 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1/2
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly assigned to one of three different intervention conditions.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
120 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06831123
Sponsor's protocol ID
STUDY00024346
Status last verified
Apr 2026
First submitted
7 Feb 2025
Last updated
13 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1/2 study testing L2B, L2B + App and skills for success in people with Conduct Disorder and Oppositional Defiant Disorder, run by University of Minnesota at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 13 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nicole Morrell (612-624-2600, morre006@umn.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Add Health Self-Report of Delinquency (time frame: Baseline; up to 15 weeks; through study completion, approximately 6 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Apr 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in